CytoMed Therapeutics Limited

About CytoMed Therapeutics Limited

CytoMed Therapeutics is a biotechnology company focused on developing affordable 'off-the-shelf' allogeneic cellular immunotherapies for a wide range of solid and hematological cancers. Incorporated in 2018 as a spin-off from Singapore's Agency for Science, Technology and Research (A*Star), the company also engages in stem cell research and therapy, translating patent-pending technologies into innovative cancer treatments.

Products & Services

iPSC-γδ NKT Cell Technology (gdNKT Therapy):A cellular immunotherapy technology using induced pluripotent stem cell-derived gamma delta NKT cells to target cancer cells.

Specialties

Cellular Immunotherapy Stem Cell Research Gamma Delta T Cell Therapy Natural Killer Cell Therapy Induced Pluripotent Stem Cells (iPSCs) Cancer Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Non-Dilutive Investment T: - FT: Non-Dilutive Investment	A: 500000 MR: - FA: up to US$500,000 FAN: 500000	D: 2025-11-06 FD: 2025-11-06	1 investors
2	RT: At-the-Market Offering T: - FT: At-the-Market Offering	A: 4304945 MR: - FA: U.S.$4,304,945 FAN: 4304945	D: 2025-08-18 FD: 2025-08-18	1 investors
3	RT: Initial Public Offering T: - FT: Initial Public Offering	A: 9649476 MR: - FA: US$9,649,476 FAN: 9649476	D: 2023-04-18 FD: 2023-04-18	2 investors
4	RT: IPO T: - FT: IPO	A: 9649476 MR: - FA: US$9,649,476.00 FAN: 9649476	D: 2023-04-13 FD: 2023-04-13	2 investors

Non-Dilutive Investment Latest

2025-11-06

$500K

1 investor (Pro only)

At-the-Market Offering 2025-08-18

$4.3M

Initial Public Offering 2023-04-18

$9.6M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

CHOO Chee Kong

Chairman and Director

L

Lucas LUK Tien Wee

Director and Chief Clinical Officer

Z

ZENG Jieming

Director and Chief Scientific and Medical Officer

G

GOH Yvonne

Chief Financial Officer

T

TAN Yoong Ying

Chief Corporate Officer

View 2 more team members with Pro

Unlock Full Team Directory

Recent News